Hyperfine, Inc.
For the period ended Sep 30, 2025. Filed Nov 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 13, 2025
HYPR$0.68-3.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows (unaudited)
(Unaudited)
(in thousands)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities: | ||
| Net loss | $(29,662) | $(30,330) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation | 809 | 775 |
| Stock-based compensation expense | 2,109 | 3,308 |
| Loss on disposal of property and equipment, net | 120 | 156 |
| Change in fair value of warrant liabilities | 639 | — |
| Other | 22 | 6 |
| Changes in assets and liabilities: | ||
| Accounts receivable, net | 1,070 | (3,611) |
| Unbilled receivables | 926 | (1,322) |
| Inventory | (221) | (579) |
| Prepaid expenses and other current assets | (802) | (324) |
| Prepaid inventory | — | 693 |
| Other long term assets | 51 | (9) |
| Accounts payable | 2,112 | 193 |
| Deferred grant funding | 438 | (402) |
| Deferred revenue | (105) | 97 |
| Due to related parties | (16) | (8) |
| Accrued expenses and other current liabilities | (221) | 949 |
| Operating lease liabilities, net | (10) | (2) |
| Net cash used in operating activities | (22,741) | (30,410) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (1,122) | (375) |
| Net cash used in investing activities | (1,122) | (375) |
| Cash flows from financing activities: | ||
| Proceeds from exercise of stock options | 130 | 160 |
| Proceeds from shares issued under “at-the-market” offering program, net of selling costs | 2,906 | 805 |
| Proceeds from issuance of common stock and warrants, net of offering costs | 5,184 | — |
| Net cash provided by financing activities | 8,220 | 965 |
| Net decrease in cash and cash equivalents and restricted cash | (15,643) | (29,820) |
| Cash, cash equivalents and restricted cash, beginning of period | 37,673 | 75,804 |
| Cash, cash equivalents and restricted cash, end of period | 22,030 | 45,984 |
| Reconciliation of cash, cash equivalents, and restricted cash reported in the balance sheets | ||
| Cash and cash equivalents | 21,564 | 45,765 |
| Restricted cash | 466 | 219 |
| Total cash, cash equivalents and restricted cash | $22,030 | $45,984 |
| Supplemental disclosure of noncash information: | ||
| Initial measurement of warrant liabilities | $2,858 | $— |
| Unpaid purchase of property and equipment | $5 | $571 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.